CRP and stroke disorder: It did not demonstrate a statistical significance between these four biomarkers and other primary and secondary outcomes in hemorrhagic stroke. Although our study did not demonstrate an association, many others have done so (as seen in Table 5), giving rise to the belief that these markers could be used to modify the management of patients with any kind of stroke [2-15, 17, 19-22]. Of the four markers, CRP and Hcy levels were elevated in 58% and 31% of patients tested, respectively.